Cite Filings / SPRO / 0001950047-23-003493

Feed Companies Filings Check

Sign in

144

Sale of Securities

Spero Therapeutics, Inc. Filed 2023-08-29 Acc 0001950047-23-003493

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2024-02-05 144 Sale of Securities
2023-09-01 ARS Annual Report to Security Holders
2023-08-30 4 Chief Development Officer sold 1,854 shares at $1.26 ($2,336)
2023-08-30 4 Chief Legal Officer sold 1,854 shares at $1.26 ($2,336)
2023-08-30 4 Director sold 9,040 shares at $1.26 ($11,390)
2023-08-30 4 CEO and President sold 6,017 shares at an average $1.29 ($7,748)
2023-08-29 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…